Search Results - "Crews, Jennie"

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline by Korde, Larissa A, Somerfield, Mark R, Carey, Lisa A, Crews, Jennie R, Denduluri, Neelima, Hwang, E Shelley, Khan, Seema A, Loibl, Sibylle, Morris, Elizabeth A, Perez, Alejandra, Regan, Meredith M, Spears, Patricia A, Sudheendra, Preeti K, Symmans, W Fraser, Yung, Rachel L, Harvey, Brittany E, Hershman, Dawn L

“…To develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer. ASCO convened an Expert Panel to conduct a systematic review of…”
Get full text

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update by Giordano, Sharon H, Temin, Sarah, Chandarlapaty, Sarat, Crews, Jennie R, Esteva, Francisco J, Kirshner, Jeffrey J, Krop, Ian E, Levinson, Jennifer, Lin, Nancy U, Modi, Shanu, Patt, Debra A, Perlmutter, Jane, Ramakrishna, Naren, Winer, Eric P, Davidson, Nancy E

“…Purpose To update evidence-based guideline recommendations for practicing oncologists and others on systemic therapy for patients with human epidermal growth…”
Get full text

Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update by Ramakrishna, Naren, Anders, Carey K, Lin, Nancy U, Morikawa, Aki, Temin, Sarah, Chandarlapaty, Sarat, Crews, Jennie R, Davidson, Nancy E, Franzoi, Maria Alice B, Kirshner, Jeffrey J, Krop, Ian E, Patt, Debra A, Perlmutter, Jane, Giordano, Sharon H

“…To provide updated evidence- and consensus-based guideline recommendations to practicing oncologists and others on the management of brain metastases for…”
Get full text

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update by Taplitz, Randy A, Kennedy, Erin B, Bow, Eric J, Crews, Jennie, Gleason, Charise, Hawley, Douglas K, Langston, Amelia A, Nastoupil, Loretta J, Rajotte, Michelle, Rolston, Kenneth, Strasfeld, Lynne, Flowers, Christopher R

“…Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA) guideline on outpatient management of fever and neutropenia in patients…”
Get full text

Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update by Giordano, Sharon H, Franzoi, Maria Alice B, Temin, Sarah, Anders, Carey K, Chandarlapaty, Sarat, Crews, Jennie R, Kirshner, Jeffrey J, Krop, Ian E, Lin, Nancy U, Morikawa, Aki, Patt, Debra A, Perlmutter, Jane, Ramakrishna, Naren, Davidson, Nancy E

“…To update evidence-based guideline recommendations to practicing oncologists and others on systemic therapy for patients with human epidermal growth factor…”
Get full text

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline by GIORDANO, Sharon H, TEMIN, Sarah, LIN, Nancy U, MODI, Shanu, PATT, Debra A, PEREZ, Edith A, PERLMUTTER, Jane, RAMAKRISHNA, Naren, WINER, Eric P, KIRSHNER, Jeffrey J, CHANDARLAPATY, Sarat, CREWS, Jennie R, DAVIDSON, Nancy E, ESTEVA, Francisco J, GONZALEZ-ANGULO, Ana M, KROP, Ian, LEVINSON, Jennifer

“…To provide evidence-based recommendations to practicing oncologists and others on systemic therapy for patients with human epidermal growth factor receptor 2…”
Get full text

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update by Ramakrishna, Naren, Temin, Sarah, Chandarlapaty, Sarat, Crews, Jennie R, Davidson, Nancy E, Esteva, Francisco J, Giordano, Sharon H, Kirshner, Jeffrey J, Krop, Ian E, Levinson, Jennifer, Modi, Shanu, Patt, Debra A, Perlmutter, Jane, Winer, Eric P, Lin, Nancy U

“…Purpose To update the formal expert consensus-based guideline recommendations for practicing oncologists and others on the management of brain metastases for…”
Get full text

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline by RAMAKRISHNA, Naren, TEMIN, Sarah, LEVINSON, Jennifer, MODI, Shanu, PATT, Debra A, PEREZ, Edith A, PERLMUTTER, Jane, WINER, Eric P, LIN, Nancy U, CHANDARLAPATY, Sarat, CREWS, Jennie R, DAVIDSON, Nancy E, ESTEVA, Francisco J, GIORDANO, Sharon H, GONZALEZ-ANGULO, Ana M, KIRSHNER, Jeffrey J, KROP, Ian

“…To provide formal expert consensus-based recommendations to practicing oncologists and others on the management of brain metastases for patients with human…”
Get full text

Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A by Crews, Jennie R, Kirshner, Jeffrey J, Temin, Sarah

Get more information

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update by Taplitz, Randy A, Kennedy, Erin B, Bow, Eric J, Crews, Jennie, Gleason, Charise, Hawley, Douglas K, Langston, Amelia A, Nastoupil, Loretta J, Rajotte, Michelle, Rolston, Kenneth V, Strasfeld, Lynne, Flowers, Christopher R

“…To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression…”
Get full text

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement by Oyer, Randall A, Hurley, Patricia, Boehmer, Leigh, Bruinooge, Suanna Steeby, Levit, Kathryn, Barrett, Nadine, Benson, Al, Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory, Crews, Jennie, DeLeon, Kyle, Fashoyin-Aje, Lola, Garrett-Mayer, Elizabeth, Gralow, Julie R, Green, Sybil, Guerra, Carmen E, Hamroun, Leila, Hardy, Claudia M, Hempstead, Bridgette, Jeames, Sanford, Mann, Mel, Matin, Khalid, McCaskill-Stevens, Worta, Merrill, Janette, Nowakowski, Grzegorz S, Patel, Manali I, Pressman, Alice, Ramirez, Amelie G, Segura, Juanita, Segarra-Vasquez, Barbara, Hanley Williams, Jen, Williams, Jr, James E, Winkfield, Karen M, Yang, Eddy S, Zwicker, Victoria, Pierce, Lori J

“…A concerted commitment across research stakeholders is necessary to increase equity, diversity, and inclusion (EDI) and address barriers to cancer clinical…”
Get full text

Use of telemedicine to expand access to survivorship care by Cole-Vadjic, Kelli Kristine, Crews, Jennie Robertson

“…Abstract only 26 Background: PeaceHealth St Joseph Cancer Center (PHSJCC) provides medical and radiation oncology services in northwest Washington. PeaceIsland…”
Get full text

A multispecialty approach to immuno-oncology education for community providers by Perloff, Tara, Dawkins, Monique, Crews, Jennie Robertson, Gregg, Jeffrey P., Abraham, Ivo, Schwartzberg, Lee S.

“…Abstract only 80 Background: The Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute was developed in 2015 to prepare all members of the…”
Get full text

Availability of data for screening, offering, and consenting patients to cancer clinical trials: Report from an ASCO-ACCC collaboration by Pressman, Alice R., Hurley, Patricia A., Kaltenbaugh, Melinda, Bruinooge, Suanna Steeby, Garrett-Mayer, Elizabeth, Boehmer, Leigh, Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory, Crews, Jennie Robertson, Fashoyin-Aje, Lola A., McCaskill-Stevens, Worta J., Nowakowski, Grzegorz S., Oyer, Randall A., Patel, Manali I., Pierce, Lori J., Ramirez, Amelie G., Hanley Williams, Jen Hanley, Zwicker, Victoria, Guerra, Carmen

“…6530 Background: Only a small fraction of patients with cancer participate in treatment trials. Patients identifying as members of racial and ethnic minority…”
Get full text

Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment by Guerra, Carmen, Pressman, Alice, Hurley, Patricia, Garrett-Mayer, Elizabeth, Bruinooge, Suanna S, Howson, Alexandra, Kaltenbaugh, Melinda, Hanley Williams, Jen, Boehmer, Leigh, Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory, Crews, Jennie, Fashoyin-Aje, Lola, McCaskill-Stevens, Worta, Merrill, Janette, Nowakowski, Greg, Patel, Manali I, Ramirez, Amelie, Zwicker, Victoria, Oyer, Randall A, Pierce, Lori J

“…Clinical trial participants do not reflect the racial and ethnic diversity of people with cancer. ASCO and the Association of Community Cancer Centers…”
Get more information

Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital by Santos, Lauren G, Buzdnitskaya, Tatyana, Rolf, Bradley A, Souza, William, Sienko, Mark, Ruiz-Bonilla, Jose Alberto, Shah, Binay, Jewell, Patrick, Jensen, Lindsay, Horike-Pyne, Martha, Elrod, Jo Ann, Crews, Jennie, Laurino, Mercy, Weeks, Kevin Austin, Dubard-Gault, Marianne E

“…Patients with cancer seen in rural and underserved areas disproportionately face barriers to access genetic services. Genetic testing is critical to inform…”
Get full text

Weekly Epoetin Alfa During Adjuvant Chemotherapy for Breast Cancer: Effect on Hemoglobin Levels and Quality of Life by Hudis, Clifford A., Vogel, Charles L., Gralow, Julie R., Williams, Denise

“…Anemia, fatigue, and diminished quality of life (QOL) often are associated with chemotherapy. In a previous study of patients with early-stage breast cancer…”
Get full text

Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant by Laughlin, M J, McGaughey, D S, Crews, J R, Chao, N J, Rizzieri, D, Ross, M, Gockerman, J, Cirrincione, C, Berry, D, Mills, L, Defusco, P, LeGrand, S, Peters, W P, Vredenburgh, J J

“…To determine the incidence of myelodysplasia (MDS) and/or acute leukemia (AL) in breast cancer patients after high-dose chemotherapy (HDC) with a single…”
Get more information

Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy by Hesketh, P J, Crews, J R, Cohen, R, Blackburn, L M, Friedman, C J

“…To compare the efficacy of oral granisetron, 1 mg and 2 mg, administered as one dose in patients who receive moderately emetogenic chemotherapy…”
Get more information

Stunned myocardium in the toxic shock syndrome by Crews, J R, Harrison, J K, Corey, G R, Steenbergen, C, Bashore, T M

Get more information